SNP Genotyping 및 분석 시장 보고서(2026년)
SNP Genotyping And Analysis Global Market Report 2026
상품코드 : 1957809
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,822,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,861,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,900,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

SNP Genotyping 및 분석 시장 규모는 최근 급격하게 확대되고 있습니다. 2025년 185억 달러에서 2026년에는 222억 4,000만 달러에 이르고, CAGR 20.2%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 유전자 검사 비용의 감소, 학술적 유전체 연구의 확대, 질병 진단의 성장, 제약 분야의 R&D 투자, 마이크로어레이 기술 개발 등에 기인하는 것으로 보입니다.

SNP Genotyping 및 분석 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 462억 9,000만 달러에 이르고, CAGR은 20.1%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 맞춤형 의료의 발전, 동반진단의 활용 확대, AI 기반 유전체 분석의 확산, 임상유전체학의 확대, 정부 주도의 유전체 관련 정책 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 정밀의료의 적용 확대, 약리유전체학의 채택 증가, cfDNA 및 액체 생검의 활용 확대, 고처리량 유전자 타이핑 플랫폼의 성장, 유전자 데이터 분석에 대한 AI 통합 등을 들 수 있습니다.

유전성 질환 증가 추세는 향후 몇 년 동안 SNP 유전형 분석 및 분석 시장의 성장을 가속할 것으로 예측됩니다. 유전성 질환은 개인의 DNA 이상에 의해 발생하는 질환으로, 부모로부터 물려받거나 세포분열 시 돌연변이에 의해 발생하는 경우가 있습니다. 유전성 질환에 대한 인식 개선과 진단 기술의 발전으로 더 많은 질환이 진단되고, 유전성 질환에 대한 인식이 높아진 것이 부담 증가의 요인입니다. SNP 유전형 분석 및 분석은 질병 위험, 진행, 약물 반응과 관련된 유전적 변이를 확인하여 유전성 질환의 관리를 돕고 조기 진단 및 맞춤 치료를 가능하게 합니다. 예를 들어, 2023년 2월 스위스에 본부를 둔 국제 공중보건기구인 세계보건기구(WHO)는 선천성 질환으로 인해 전 세계적으로 매년 약 24만 명의 신생아가 생후 28일 이내에 사망하고 있다고 보고했습니다. 또한, 생후 1개월에서 5세까지의 소아에서 17만 명이 추가로 사망한 것으로 보고되고 있습니다. 따라서 유전성 질환의 부담이 증가함에 따라 SNP 유전형질 분석 시장의 성장을 가속하고 있습니다.

SNP 유전형질 분석 시장의 주요 기업들은 이중배체 종의 분자 육종 유전형질 분석의 과제를 해결하기 위해 농업용 대규모 로우패스 전장 유전체 염기서열 분석과 같은 첨단 솔루션 개발에 주력하고 있습니다. 농업용 전장유전체 시퀀싱은 작물이나 가축의 완전한 유전물질을 해독하여 수확량, 내병성, 환경 적응성 등의 특성을 개선하는 기술입니다. 예를 들어, 2024년 6월 중국 기반 생명공학 기업 MGI Tech는 농업용 대규모 로우패스 전장 유전체 염기서열 분석(Low-pass WGS)을 위한 고효율 워크플로우 솔루션을 발표했습니다. 이 솔루션은 DNA 추출, 라이브러리 준비, 시퀀싱, SNP 및 InDel 콜을 포괄하는 자동화 된 전체 프로세스 제품 포트폴리오를 포함하며, 특히 이배체 종의 분자 육종 유전형질 분석을 위해 설계되었습니다. MGI의 DNBSEQ-T7 및 DNBSEQ-G400 시퀀서를 활용한 고도의 자동화 플랫폼이 특징이며, 높은 처리량과 유연성을 제공합니다. 또한, 워크플로우에는 돼지 참조 패널과 데이터 분석 소프트웨어가 포함되어 있어 맞춤형 데이터베이스를 만들지 않고도 유전형 분석을 할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

SNP genotyping and analysis involves the identification and examination of single nucleotide polymorphisms-variations at a single base pair in the genome-across individuals or populations using molecular techniques such as PCR, microarrays, or sequencing. This process allows researchers to study genetic diversity, trace inheritance patterns, and understand individual differences in drug response or susceptibility to various conditions.

The main types of samples used in SNP genotyping and analysis include genomic DNA, ribonucleic acid (RNA), cell-free DNA (cfDNA), plasma samples, and whole blood. Genomic DNA represents the complete set of DNA in an organism, containing all genetic instructions necessary for its development and function. Tests are performed using technologies such as microarrays and gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, Sequenom MassArray MALDI-TOF, and others. These analyses are applied in disease diagnostics, pharmacogenomics, precision medicine, forensic science, agriculture, and livestock. End users include hospitals and clinics, research laboratories, pharmaceutical and biotechnology companies, diagnostic laboratories, and academic and government institutions.

Tariffs have impacted the SNP genotyping and analysis market by increasing the cost of imported sequencing instruments, consumables, and diagnostic reagents used in genetic analysis workflows. These impacts are most pronounced in research intensive regions across Asia Pacific and Europe, where laboratories rely heavily on globally sourced technologies. Rising tariff related expenses have increased operational costs and placed pressure on research budgets and testing service pricing. This has influenced procurement planning and slowed adoption of advanced genotyping platforms in some settings. However, tariffs have encouraged regional manufacturing, localized reagent production, and improved long term supply chain resilience.

The snp genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides snp genotyping and analysis market statistics, including snp genotyping and analysis industry global market size, regional shares, competitors with a snp genotyping and analysis market share, detailed snp genotyping and analysis market segments, market trends and opportunities, and any further data you may need to thrive in the snp genotyping and analysis industry. This snp genotyping and analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The snp genotyping and analysis market size has grown exponentially in recent years. It will grow from $18.5 billion in 2025 to $22.24 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to declining cost of genetic testing, expansion of academic genomics research, growth in disease diagnostics, pharmaceutical r&d investment, development of microarray technologies.

The snp genotyping and analysis market size is expected to see exponential growth in the next few years. It will grow to $46.29 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to growth in personalized medicine, increased use of companion diagnostics, ai-driven genomic analytics, expansion of clinical genomics, government genomics initiatives. Major trends in the forecast period include expansion of precision medicine applications, rising adoption of pharmacogenomics, increased use of cfdna and liquid biopsy, growth of high-throughput genotyping platforms, integration of ai in genetic data analysis.

The increasing burden of genetic diseases is expected to drive the growth of the SNP genotyping and analysis market in the coming years. Genetic diseases are disorders caused by abnormalities in an individual's DNA, which may be inherited from parents or arise due to mutations during cell division. The burden of genetic diseases is rising due to greater awareness and improved diagnostic technologies, leading to more diagnoses and higher recognition of genetic disorders. SNP genotyping and analysis support genetic disease management by identifying genetic variations linked to disease risk, progression, and drug response, enabling early diagnosis and personalized treatments. For example, in February 2023, the World Health Organization, a Switzerland-based international public health agency, reported that congenital disorders caused approximately 240,000 newborn deaths worldwide within the first 28 days of life each year, along with an additional 170,000 deaths among children aged 1 month to 5 years. Therefore, the growing burden of genetic diseases is driving the growth of the SNP genotyping and analysis market.

Major companies in the SNP genotyping and analysis market are focusing on developing advanced solutions, such as large-scale low-pass whole genome sequencing for agriculture, to address challenges in molecular breeding genotyping of diploid species. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to improve traits such as yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a China-based biotechnology company, launched a highly efficient workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). The solution includes an automated full-process product portfolio covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, specifically designed for molecular breeding genotyping of diploid species. It features advanced automation platforms and leverages MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers to achieve ultra-high throughput and flexibility. The workflow also includes pig reference panels and data analysis software to enable genotyping without the need for custom database creation.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc., for an undisclosed amount. This acquisition strengthens QIAGEN's leadership in human identification and forensics by integrating Verogen's advanced NGS tools and bioinformatics solutions into its Sample to Insight portfolio. Verogen Inc., a US-based biotechnology company, offers SNP genotyping and analysis through its Forenseq Kintelligence kit and universal analysis software.

Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

North America was the largest region in the SNP genotyping and analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the snp genotyping and analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the snp genotyping and analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

SNP Genotyping And Analysis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses snp genotyping and analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for snp genotyping and analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The snp genotyping and analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. SNP Genotyping And Analysis Market Characteristics

3. SNP Genotyping And Analysis Market Supply Chain Analysis

4. Global SNP Genotyping And Analysis Market Trends And Strategies

5. SNP Genotyping And Analysis Market Analysis Of End Use Industries

6. SNP Genotyping And Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global SNP Genotyping And Analysis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global SNP Genotyping And Analysis Total Addressable Market (TAM) Analysis for the Market

9. SNP Genotyping And Analysis Market Segmentation

10. SNP Genotyping And Analysis Market Regional And Country Analysis

11. Asia-Pacific SNP Genotyping And Analysis Market

12. China SNP Genotyping And Analysis Market

13. India SNP Genotyping And Analysis Market

14. Japan SNP Genotyping And Analysis Market

15. Australia SNP Genotyping And Analysis Market

16. Indonesia SNP Genotyping And Analysis Market

17. South Korea SNP Genotyping And Analysis Market

18. Taiwan SNP Genotyping And Analysis Market

19. South East Asia SNP Genotyping And Analysis Market

20. Western Europe SNP Genotyping And Analysis Market

21. UK SNP Genotyping And Analysis Market

22. Germany SNP Genotyping And Analysis Market

23. France SNP Genotyping And Analysis Market

24. Italy SNP Genotyping And Analysis Market

25. Spain SNP Genotyping And Analysis Market

26. Eastern Europe SNP Genotyping And Analysis Market

27. Russia SNP Genotyping And Analysis Market

28. North America SNP Genotyping And Analysis Market

29. USA SNP Genotyping And Analysis Market

30. Canada SNP Genotyping And Analysis Market

31. South America SNP Genotyping And Analysis Market

32. Brazil SNP Genotyping And Analysis Market

33. Middle East SNP Genotyping And Analysis Market

34. Africa SNP Genotyping And Analysis Market

35. SNP Genotyping And Analysis Market Regulatory and Investment Landscape

36. SNP Genotyping And Analysis Market Competitive Landscape And Company Profiles

37. SNP Genotyping And Analysis Market Other Major And Innovative Companies

38. Global SNP Genotyping And Analysis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The SNP Genotyping And Analysis Market

40. SNP Genotyping And Analysis Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기